Healthcare Global Enterprises Ltd Company History

Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited

India Development Fund made its first investment of 500 million in the Company

BMORCL became the Subsidiary

HCG Medi-Surge became the Subsidiary

Evolvence made its first investment of 225 million in the Company

NTICPL made its first investment of 400 million in the Company

Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company

IL&FS Trust Company Limited a/c MPEF, through its scheme India Build Out Fund I and MAT made its first investment of 312 million in the Company

Amalgamation of BMORCL with the Company

PIOF became a Shareholder by purchasing shares from NTICPL

V-Sciences made its first investment of `600 million in the Company

Entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare

Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company

HCG Regency became the Subsidiary

Amalgamation of HCG Vijay with the Company

HCG was recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India in 2015 for its in-house research and development activities at HCG Towers, Bengaluru.

At Frost and Sullivan 7th Annual Indian Healthcare Excellence Awards in 2015, Milann was recognised as the ‘Emerging IVF Service Provider Company of the Year’.

Company has entered into a Joint Venture Agreement on November 22, 2016, with HCG Regency Oncology Healthcare Pvt. Ltd

All India Critical Care Hospital Ranking Survey - 2016

HCG Launches Advanced Comprehensive Cancer Centre in Baroda

Launch of HCG Vizag

HCG inaugurates TomoTherapy at its Centre of Excellence

HCG - The Specialist in Cancer Care has been presented with the prestigious title of the ‘Best Medical Tourism Centre of Gujarat’ during the Tourism Awards 2017 event.

HCG The Specialist in Cancer Care has been presented with the prestigious title of the ‘Best Medical Tourism Centre of Gujarat’ during the Tourism Awards 2017 event.

Healthcare Global Enterprises Limited has approved the Scheme of Amalgamation of DKR with BACC on January 29, 2018 (?the Scheme?). BACC is a subsidiary of the Company, and DKR is a wholly owned subsidiary of BACC.

HCG Hospitals, Bhavnagar was recognised as the ‘Best Multispeciality Hospital’ in Bhavnagar by Saurashtra Samachar in 2018.

HCG Cancer Centre, Ahmedabad was awarded as the ‘Best Cancer Hospital’ by DivyaBhaskar in 2018.

Milann has been honoured with The National Icon Award 2018-19 for being ‘India’s Most Trusted IVF Centre’.

During the 6th India Health and Wealth Awards in 2020, HealthCare Global Enterprises Ltd was recognised for its efficient COVID management initiatives.

During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the ‘Silver Award’ under the COVID Care Brand category.

During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the ‘Silver Award’ under the COVID Care Brand category.

Three centres from the HCG network, namely Bangalore, Mumbai and Vadodara bagged 1st, 3rd and 6th positions under the National Single Speciality – Oncology category in the Times Health’s All India Critical Care Hospital Ranking Survey 2021.

Milann has been recognised as ‘The Best Fertility and IVF Chain in India’ by ET Healthcare Brands.

HCG Cancer Centre, Ahmedabad, has been honoured with the Times Healthcare Leaders Ahmedabad 2021 Awards for ‘Excellence in Oncology’ and ‘Excellence in Innovative Technology’.

HCG Cancer Centre, Ahmedabad, was ranked amongst the World’s Best Hospitals 2021 by Newsweek Magazine.